What is Acadia Healthcare's government investigations?

Acadia Healthcare (ACHC) reported government investigations of $12.42M in Q1 2026.

How has Acadia Healthcare's government investigations changed year-over-year?

Acadia Healthcare's government investigations decreased by 59.9% year-over-year, from $31.01M to $12.42M.

Revenue$828.8M+7.6%

Net income$4.1M-51.0%

EPS (diluted)$0.05-44.4%

Cash & equivalents$158.5M+73.7%

Total debt$2.7B+14.7%

Total equity$2.0B-35.6%

Total assets$5.5B-9.8%

Operating cash flow$61.5M+436%

CapEx$76.6M-56.2%

Free cash flow-$15.0M+90.8%

Market cap$2.26B-23.6%

Enterprise value$4.77B-7.7%

P/S0.7×-0.3×

Net margin-32.8%-38.8pp

FCF margin-8.7%-0.1pp

Return on equity-44.3%-50.6pp

Debt / equity1.4×+0.6×

Current ratio1.7×+0.4×

Reported directly by Acadia Healthcare in its filing.

Tagged under the XBRL concept achc:GovernmentInvestigations.

The official record: Acadia Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Acadia Healthcare's government investigations?: Acadia Healthcare (ACHC) reported government investigations of $12.42M in Q1 2026.
How has Acadia Healthcare's government investigations changed year-over-year?: Acadia Healthcare's government investigations decreased by 59.9% year-over-year, from $31.01M to $12.42M.